Boston Scientific Corporation vs Global X Cybersecurity — how do they compare? Boston Scientific Corporation trades at $42.65 (market cap $66.37B), while Global X Cybersecurity trades at $42.48. The key difference: Global X Cybersecurity is trading nearer its 52-week high, Boston Scientific Corporation nearer its low. Which is the better fit depends on your goals.
| BSX | BUG | |
|---|---|---|
Market Cap | $66.37B | — |
Sector | Health | Sector/Thematic |
52-Week High | $108.14 | $41.99 |
52-Week Low | $42.63 | $23.30 |
Enterprise Value | $75.94B | — |
Trailing returns across standard periods
Latest headlines on both assets
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
Read more on BSX →BUG is a thematic ETF that invests in companies at the forefront of the global cybersecurity industry. It provides concentrated exposure to leaders in network security, endpoint protection, and cloud security, such as Fortinet, Akamai, and CrowdStrike.
Read more on BUG →